Molecular biomarker for cytoreductive nephrectomy?

Tobias Klatte, MD, PhD, FEBU, FRCS(Ed)<br />Consultant Urological Surgeon, Royal Bournemouth Hospital Visiting Researcher, University of Cambridge Honorary Lecturer, University of Edinburgh asks the quest... Author: kidneycancer Added: 03/29/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts